National Institutes of Health Awards SBIR Grant to MediBeacon™ Inc.
NIH Grant to Support Research on MediBeacon Fluorescent Tracer Agent Use in Ocular Angiography (SAINT LOUIS, MO, August 8, 2016) – MediBeacon announced today that it is the recipient of a Small...
View ArticleGates Foundation Awards $1.1 Million Grant for MediBeacon™ Collaboration with...
MediBeacon Inc. Collaborates with Washington University in $1.1 Million Grant for Groundbreaking Research in Global Health and Development (SAINT LOUIS, MO, October 18, 2016) – MediBeacon Inc....
View ArticleMediBeacon Presents Multiple Papers at SPIE Photonics West
Transdermal Fluorescent Detection Technology for Use in Nephrology Advances (SAN FRANCISCO, January 30, 2017) – Three papers related to continued advances in the use of transdermal fluorescent...
View ArticleMediBeacon™ Inc. Completes Successful Clinical Study of Transdermal...
Expanded Multicenter Study in U.S. and Europe to Begin Fourth Quarter 2017 (SAINT LOUIS, MO, March 2, 2017) – MediBeacon Inc., a portfolio company within the Pansend Life Sciences platform of HC2...
View ArticleMediBeacon Presents Gastrointestinal Permeability Research
(CHICAGO – May 6, 2017) – Dr. Richard B. Dorshow, Ph.D., Chief Scientific Officer of MediBeacon and Phillip I. Tarr MD, Director of the Division of Pediatric Gastroenterology, Hepatology and Nutrition...
View ArticleFDA Grants Breakthrough Device Status for MediBeacon’s Transdermal GFR...
MediBeacon’s Breakthrough Device is Intended to Measure GFR in Patients with Impaired or Normal Kidney Function ST. LOUIS, October 22, 2018 – MediBeacon Inc., whose largest shareholder is Pansend Life...
View ArticleMediBeacon Enters into $30 Million Investment and Exclusive Commercialization...
MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon’s entire portfolio of assets in Greater China ST. LOUIS, July 31, 2019 – MediBeacon Inc., whose...
View ArticleMediBeacon Inc. hires Vice President of Research and Development
MediBeacon has hired James M. Harr, a former Global Vice President of R&D at Medtronic ST. LOUIS, February 13, 2020 – MediBeacon Inc. announced today that they have hired James M. Harr in the role...
View ArticleMediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine...
MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of five required PMA modules needed for FDA approval ST. LOUIS, November 16, 2022 – MediBeacon Inc., a...
View ArticleMediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer
MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 – MediBeacon Inc., a portfolio company within the Pansend Life Sciences...
View Article